Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

182 results about "Pleuromutilin" patented technology

Pleuromutilin and its derivatives are antibacterial drugs that inhibit protein synthesis in bacteria by binding to the peptidyl transferase component of the 50S subunit of ribosomes. This class of antibiotics includes the licensed drugs lefamulin (for systemic use in humans), retapamulin (approved for topical use in humans), valnemulin and tiamulin (approved for use in animals) and the investigational drug azamulin.

Novel pleuromutilin derivate, preparation method and medical use thereof

The invention discloses a pleuromutilin derivate, a preparation method and medical use thereof. The pleuromutilin derivate is a compound, which is obtained by coupling pleuromutilin to alkyl acylamino-thiazole-4-methyl merecaptan with 2-different substitutional amino. Pharmacological experimental results show that: compared with the pleuromutilin, the pleuromutilin derivate disclosed by the invention has better antimicrobial and antibiotic resistant bacteria activities; and therefore, the compound is possibly applicable for curing a plurality of infection and inflammatory diseases on clinic.
Owner:南通药享科技有限公司

Method for synthesizing valnemulin hydrochloride

The invention discloses a method for synthesizing valnemulin hydrochloride. The method taking pleuromytilin a raw material comprises the following steps: synthesizing sulfonated pleurin; then, preparing 14-O-[(1-amido-2-methyl-propyl-2-yl)acetyl] mutelin by the sulfonated pleurin; synthesizing D-valine deng salt by D-valine; and finally, mixing the 14-O-[(1-amido-2-methyl-propyl-2-yl)acetyl] mutelin, the D-valine deng salt, N-methylmorpholine and allyl chloroformate by a certain sequence and a certain condition and reacting to generate mixed anhydride so as to obtain the valnemulin hydrochloride by the subsequent steps of acidylating, hydrolyzing, separating, drying and the like. The invention realizes the accurate control of the reaction by controlling the technological parameters of the reaction temperature, the drying condition, the reaction pH and the like and enhances the reaction efficiency and the quality and the purity of a product effectively. The obtained valnemulin hydrochloride can be used for medicines and meets the market requirement.
Owner:SHANDONG SHENGLI CO LTD

Preparation method of tiamulin base

InactiveCN102675172AHarm reductionReduce salt formation and crystallization stepsSulfide preparationReaction temperatureKetone
The invention relates to a preparation method of tiamulin base. The preparation method includes: filtering pleuromulin fermentation broth, drying mycelium, performing leaching by using methanol as solvent, using acetone to extract leach liquor after vacuum concentration, concentrating extract, transferring concentrate into a synthetic reactor, adding paratoluensulfonyl chloride, allowing for synthetic reaction at pH of 11-12 and reaction temperature of 20-30 DEG C, allowing for standing and layering after complete reaction, adding tetrabutylammonium bromide and diethylaminoethyl mercaptide into ketone phase respectively , allowing for full reaction at pH of 9-10 and the reaction temperature of 50-60 DEG C, adding water for extraction, discarding aqueous phase, filtering the ketone phase, and reducing the original volume to 60-70% by vacuum concentration to obtain tiamulin base. The original process is improved, the salifying and crystallization process is omitted, the tiamulin base is used to produce preparations directly, and accordingly equipment investment cost and production cost are lowered, product quality is improved, and the content of tiamulin base reaches 80-90%. Organic solvents used in the preparation method are recyclable, environmental pollution is reduced, and the preparation method has promising development prospect.
Owner:宁夏泰瑞制药股份有限公司

Pleuromutilin phosphate compounds, medicinal composition thereof, preparation method thereof and application thereof

The invention belongs to the field of pharmaceutics, and provides pleuromutilin phosphate compounds shown as a right general formula (I), a medicinal composition thereof, a preparation method thereofand application thereof. The pleuromutilin phosphate compounds have good water solubility, quickly release parent medicaments in vivo after intravenous administration, achieve higher blood concentration, and have excellent anti-infectious activity, so the pleuromutilin phosphate compounds can be used for treating infectious diseases, particularly infectious diseases caused by multi-medicament andmedicament-resistant bacteria.
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI +1

Pleuromutilin derivative with pyrimidine side chain and application of pleuromutilin derivative

The invention discloses a pleuromutilin derivative with a pyrimidine side chain. The structural formula of the derivative is shown in the specification, wherein R1 is C1-C4 alkoxy groups or hydroxyl groups; R2 is an amino group or an amide group; R3 is hydrogen or C1-C4 alkyl groups. The compound can be applied to preparation of antibacterial drugs, particularly to preparation of MRSA (methicillin-resistant staphylococcus aureus), MRSE (methicillin-resistant staphycoccus epidermidis) and / or antagonistic bacillus subtilis drugs, and the antibacterial effect is superior to that of tiamulin.
Owner:山东齐发药业有限公司

Pleuromutilin derivatives with antibacterial activity as well as preparation method and application thereof

The invention discloses pleuromutilin derivatives with the structure as shown in a formula (I) in the specification and the antibacterial activity, salts, solvates, optical isomers and polymorphism compounds thereof acceptable in pharmacy and / or veterinary medicines as well as a preparation method and an application of the pleuromutilin derivatives and the salts, solvates, optical isomers and polymorphism compounds thereof in antibacterial compositions. The preparation method has the beneficial effects that two different lead compounds are connected together by covalent bonds so as to generate a synergistic effect, an additive effect or new pharmacological activity in vivo; sulfonamides are spliced into side chains of pleuromutilin so as to generate new pleuromutilin derivatives, the antibacterial activity of the obtained new compounds can be enhanced, the obtained new compounds have obvious antibacterial activity for gram-positive bacterium, gram-negative bacterium and mycoplasma and an obvious inhibiting effect on drug-resistance bacteria such as MRSA, and the antibacterial spectrums of the obtained new compounds are effectively expanded.
Owner:SOUTH CHINA AGRI UNIV +1

Pleuromutilin antibiotic derivatives

The present invention relates to pleuromutilin antibiotic derivatives represented by a general formula (I), pharmaceutically acceptable salts, prodrugs, solvates or stereoisomers thereof, wherein R<2>, Q<1>, Q<2>, m and X are defined in an instruction. The present invention further relates to preparation methods of the compounds, drug compositions containing the compounds, drug preparations containing the compounds, and applications of the compounds in preparation of drugs for treatment and / or prevention of diseases caused by microorganisms.
Owner:KBP BIOSCIENCES CO LTD

Synthesis method of p-toluene sulfonic acid pleuromutilin ester

The invention relates to a synthesis method of p-toluene sulfonic acid pleuromutilin ester. Especially, the method includes: under catalysis of three inorganic alkalis, i.e. sodium hydroxide, potassium hydroxide or sodium carbonate, reacting pleuromutilin with p-toluenesulfonyl chloride for 0.5-1.5h in a methyl isobutyl ketone solvent at 50-65DEG C, conducting washing and distillation of the solvent, thus obtaining the p-toluene sulfonic acid pleuromutilin ester with yield of 95-96.5% and chromatographic purity of 97-98.1%. The method has the advantages of environmental-friendliness, worker health promotion, low production cost, short synthesis reaction time and high yield.
Owner:大英九合药业有限公司

Adsorption chromatograph based method for recovering pleuromutilin from crystallization mother liquor

An adsorption chromatograph based method for recovering pleuromutilin from a crystallization mother liquor, belongs to the technical field of separation and purification of antibiotic. The method is characterized by comprising steps of: carrying out a vacuum concentration on a pleuromutilin crystallization mother liquor, heating to 90 DEG C gradually until no distillate, adding water-soluble organic solvent and stirring uniformly; pumping into nonpolar macroporous adsorption resin column for adsorption; preparing an eluant by a water-soluble organic solvent with volume percentage of 20-70% and pumping into an adsorption resin column for desorption; carrying out vacuum condensation on the obtained eluate, adding organic solvent, dissolving, recrystallizing and carrying out vacuum drying to obtain a finished product. The invention has beneficial effects that the adsorption chromatograph based method for recovering pleuromutilin from the crystallization mother liquor has simple technique, low production costs, and a residual pleuromutilin recovery rate from the crystallization mother liquor reaches 85-92%, and a total production recovery rate reaches 95-98%, so as to increase industrial production efficiency.
Owner:上海华震科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products